During the rapid spread of HIV-1 in humans, the main (M) group of HIV-1 has evolved into
ten distinct subtypes, undergone countless recombination events and diversified …

The devastating consequences of AIDS pandemic will probably only be controlled when a
vaccine is developed that is safe, effective, affordable, and simple enough to permit …

Reports of HIV-1 superinfection (re-infection) have demonstrated that the immune response
generated against one strain of HIV-1 does not always protect against other strains …

Recombinants based on the attenuated vaccinia virus strains MVA and NYVAC are
considered candidate vectors against different human diseases. In this study we have …

There is an urgent need for low-cost assays for HIV-1 quantitation to ensure adequate follow-
up of HIV-infected patients on antiretroviral therapy (ART) in resource-limited countries. Two …

This study characterized HIV-1 among antiretroviral-naïve populations presenting recent
infection (RI) or long-standing infection (LSI). Sera collected from January 1999 to …

To understand the predominant HIV subtype and drug-resistant viruses in northwest
Ethiopia, isolates from 92 antiretroviral drug-naive HIV-1-infected tuberculosis patients were …

Multiple HIV-1 subtypes and circulating recombinant forms (CRFs) are known to circulate in
West Africa. We undertook a survey of HIVs in Oyo state, in southwestern Nigeria. We …

The isolation of primary strains of human immunodeficiency virus (HIV) is an invaluable tool
for assessing properties of viruses replicating in HIV-infected subjects. A common method …

The HIV protease-reverse transcriptase (PR-RT)(1047 bp), gp120-env (891 bp) and gp41-
env (547 bp) regions from the plasma of 115 HIV-1-infected patients in Kuala Lumpur (KL) …